ADXN peer analysis
Addex Therapeutics (ADXN) against its competitors: price, today's move, 1-year return and market value side by side.
ADXN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ADIL Adial Pharmaceuticals | $5.05 | 36.12% | -46.48% | $13.26M |
| CDIO Cardio Diagnostics | $1.87 | -2.60% | -49.61% | $5.68M |
| IBO Impact BioMedical | $4.30 | -6.93% | -38.49% | $37.15M |
| MTNB Matinas BioPharma | $0.92 | -1.25% | -94.83% | $397.18K |
| NRSN NeuroSense Therapeutics | $1.76 | -1.12% | -90.76% | $3.38M |
| QNRX Quoin Pharmaceuticals | $3.76 | 0.80% | -67.33% | $7.55M |
| RADX Radiopharm | $0.79 | -3.66% | -83.59% | $1.06M |
| TCRT Alaunos Therapeutics | $1.62 | 0.62% | -41.34% | $4.22M |
| ADXN Addex Therapeutics | $5.29 | 83.04% | – | $3.56M |
- ADXN's peers: ADIL (Adial Pharmaceuticals), CDIO (Cardio Diagnostics), IBO (Impact BioMedical), MTNB (Matinas BioPharma), NRSN (NeuroSense Therapeutics), QNRX (Quoin Pharmaceuticals), RADX (Radiopharm), TCRT (Alaunos Therapeutics).
Updated 2026-11-13 11:50 UTC